Navigation Links
Hybrid Fuels, Inc. Announces New Business Strategy
Date:12/5/2011

FORT LAUDERDALE, Fla., Dec. 5, 2011 /PRNewswire/ -- Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today a reorientation of its main business activities and new strategic goals. 

The company will transform itself into a nutraceutical/pharmaceutical business venture that will focus on providing natural or nutraceutical solutions to medical conditions that would normally be treated or addressed with pharmaceutical drugs that are more damaging and can cause side effects that are sometimes even more harmful than the condition being treated.  The company's niche in the market place will be to provide nutraceutical alternatives and solutions to patients ranging from impotence, acne, cholesterol and many other common conditions. 

"Despite globalization, rocky economics and an uneasy healthcare system, the dietary supplement market continues to grow already boasting an estimated $25 billion in U.S. sales.  According to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition, 65% of adult Americans (approx. 150 million) label themselves as supplement users.  The acquisition of EMG Marketing Solutions was the first step in implementing our new strategic goals focused on this evolving market.  EMB not only brings seasoned leadership in the nutraceutical industry but patented product formulations that are proven to help treat every day health conditions.  We look forward to announcing product lines in production over the next couple of weeks," stated Philip Schmidt, CEO of Hybrid Fuels, Inc.           

About Hybrid Fuels, Inc.

The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

CONTACT:
Hybrid Fuels, Inc. - 954-903-2993

 


'/>"/>
SOURCE Hybrid Fuels, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
2. MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux
3. Cardicas Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting
4. Frost & Sullivan Award Highlights Hybridyne Technologies Outstanding Technology Innovation
5. Philips and ACC Address the Growing Demand for Minimally Invasive Cardiology Interventions by Showcasing Hybrid OR Solutions at ACC 2010
6. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
7. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
8. WestPark Capital, Inc. Announces $2.6 Million IsoRay Offering
9. WestPark Capital Announces $2.6 Million IsoRay Offering
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):